Terris-Prestholt, F., Watson-Jones, D., Mugeye, K., Kumaranayake, L., Ndeli, L., Weiss, H., Changalucha, J., Todd, J., Lisekie, F., Gumodoka, B., Mabey, D. and Hays, R. (2003) Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sexually Transmitted Infections, 79 (5). pp. 375-381.
ihi_(54).pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.
Objectives: To estimate the cost effectiveness of on-site antenatal syphilis screening and treatment in
Mwanza, Tanzania. To compare this intervention with other antenatal and child health interventions,
specifically the prevention of mother to child transmission of HIV (PMTCT).
Methods: The economic costs of adding the intervention to routine antenatal care were assessed. Cost
effectiveness (CE) ratios of the intervention were obtained for low birth weight (LBW) live births and
stillbirths averted and cost per DALY saved. Cost per DALY saved was also estimated for previous CE
studies of syphilis screening. The CE of the intervention at different syphilis prevalence rates was modelled.
Results: The economic cost of the intervention is $1.44 per woman screened, $20 per woman treated, and
$187 per adverse birth outcome averted. The cost per DALY saved is $110 with LBW as the only adverse
outcome. When including stillbirth, this estimate improves 10-fold to $10.56 per DALY saved. The cost per
DALY saved from all syphilis screening studies ranged from $3.97 to $18.73.
Conclusions: Syphilis screening is shown to be at least as cost effective as PMTCT and more cost effective
than many widely implemented interventions. There is urgent need for scaling up syphilis screening and
treatment in high prevalence areas. The CE of screening interventions is highly dependent on disease
prevalence. In combination, PMTCT and syphilis screening and treatment interventions may achieve
economies of scope and thus improved efficiency.
|Keywords:||antenatal syphilis, sub-saharan Africa, screening and treatment in Mwanza, Tanzania, sexual transmitted infections.|
|Subjects:||Health Systems > Surveillance, monitoring & evaluation
Maternal & Neonatal Health > Antenatal care
|Depositing User:||Mr Joseph Madata|
|Date Deposited:||28 Aug 2012 09:24|
|Last Modified:||29 Aug 2012 07:46|
Actions (login required)
Downloads per month over past year